Hypoxia-induced expression of complement receptor type 1 (CR1, CD35) in human vascular endothelial cells

被引:27
作者
Collard, CD
Bukusoglu, C
Agah, A
Colgan, SP
Reenstra, WR
Morgan, BP
Stahl, GL
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesia,Ctr Expt Therapeut & Reperfus Inj, Boston, MA 02115 USA
[2] Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA
[3] Cardiff Univ, Dept Biochem Med, Cardiff CF4 4XN, S Glam, Wales
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 1999年 / 276卷 / 02期
关键词
cytokines; tumor necrosis factor; human umbilical vein endothelial cells; C3b; cofactor activity; immune complex;
D O I
10.1152/ajpcell.1999.276.2.C450
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Reoxygenation of hypoxic human umbilical vein endothelial cells (HUVECs) increases protein expression of the complement regulators CD46 and CD55. As the receptor for C3b is known to be present on injured bovine endothelial cells, we investigated whether hypoxia or inflammatory mediators induce complement receptor type 1 (CR1; CD35) expression on HUVECs. CR1 protein expression increased 3.7 +/- 0.6-fold as measured by ELISA on HUVECs following hypoxia (48 h, 1% O-2) Colocalization of CD35 and von Willebrand factor by confocal microscopy confirmed that CD35 was predominantly intracellular. Lipopolysaccharide or tumor necrosis factor-alpha also significantly increased HUVEC CR1 protein expression. Western blot analysis of neutrophil or hypoxic HUVEC lysates revealed a 221-kDa CR1 band under nonreducing conditions. RT-PCR of hypoxic HUVEC mRNA revealed a single band that, after sequencing, was identified as CD35. In situ hybridization of hypoxic HUVECs, but not normoxic HUVECs or fibroblasts, demonstrated increased CD35 mRNA. Hypoxic HUVECs bound immune complexes and acted as a cofactor for factor I-mediated cleavage of C3b. Thus hypoxia induces functional HUVEC CR1 expression.
引用
收藏
页码:C450 / C458
页数:9
相关论文
共 25 条
[1]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[2]   ORGANIZATION OF THE GENES ENCODING COMPLEMENT RECEPTORS TYPE-1 AND TYPE-2, DECAY-ACCELERATING FACTOR, AND C4-BINDING PROTEIN IN THE RCA LOCUS ON HUMAN CHROMOSOME-1 [J].
CARROLL, MC ;
ALICOT, EM ;
KATZMAN, PJ ;
KLICKSTEIN, LB ;
SMITH, JA ;
FEARON, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1271-1280
[3]  
Collard CD, 1997, CIRCULATION, V96, P326
[4]  
CUI WI, 1993, J IMMUNOL, V151, P4137
[5]   POSTREPERFUSION INFLAMMATION - A MODEL FOR REACTION TO INJURY IN CARDIOVASCULAR-DISEASE [J].
ENTMAN, ML ;
SMITH, CW .
CARDIOVASCULAR RESEARCH, 1994, 28 (09) :1301-1311
[6]   INVIVO AND INVITRO ASSESSMENT OF PORCINE NEUTROPHIL ACTIVATION RESPONSES TO CHEMOATTRACTANTS - FLOW CYTOMETRIC EVIDENCE FOR THE SELECTIVE ABSENCE OF FORMYL PEPTIDE RECEPTORS [J].
FLETCHER, MP ;
STAHL, GL ;
LONGHURST, JC .
JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 47 (04) :355-365
[7]   COMPLEMENT ACTIVATION AND INHIBITION IN MYOCARDIAL-ISCHEMIA AND REPERFUSION INJURY [J].
HOMEISTER, JW ;
LUCCHESI, BR .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :17-40
[8]   THE COMPLEMENT-SYSTEM IN MYOCARDIAL ISCHAEMIA/REPERFUSION INJURY [J].
KILGORE, KS ;
FRIEDRICHS, GS ;
HOMEISTER, JW ;
LUCCHESI, BR .
CARDIOVASCULAR RESEARCH, 1994, 28 (04) :437-444
[9]   IDENTIFICATION OF DISTINCT C3B AND C4B RECOGNITION SITES IN THE HUMAN C3B/C4B RECEPTOR (CR-1, CD35) BY DELETION MUTAGENESIS [J].
KLICKSTEIN, LB ;
BARTOW, TJ ;
MILETIC, V ;
RABSON, LD ;
SMITH, JA ;
FEARON, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (05) :1699-1717
[10]   Complement receptor type 1 (CR1, CD35) is a receptor for C1q [J].
Klickstein, LB ;
Barbashov, SF ;
Liu, T ;
Jack, RM ;
NicholsonWeller, A .
IMMUNITY, 1997, 7 (03) :345-355